NeilAdrianZakaiMD

Assistant Professor, Medicine, University of Vermont College of Medicine

Dr. Zakai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
S Prospect St
# 89
Burlington, VT 05405
Phone+1 802-847-5971

Fax+1 802-847-5946

Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
University of Vermont Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Virginia School of MedicineClass of 2000

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Journal Articles

All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism
Neil A Zakai, Terrence J Adam, Thrombosis and Haemostasis
Mechanisms and Mitigating Factors for Venous Thromboembolism in Chronic Kidney Disease: The REGARDS Study
M Cushman, N A Zakai, G Howard, Journal of Thrombosis and Haemostasis
Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)
Monika M Safford, Mary Cushman, Brett Kissela, Neil A Zakai, Thrombosis and Haemostasis

Abstracts/Posters

Post Discharge Risk of Venous Thromboembolism in a Primary Care Population
Neil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium
Neil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
The ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning
Neil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention
Neil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Alpha Globin Gene Copy Number Is Associated with Kidney Disease Among Black Individuals
Neil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Diagnosis and Follow‐up of Thrombotic Thrombocytopenic Purpura with an Automated Chemiluminescent ADAMTS13 Activity ImmunoassayDecember 15th, 2020
Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel MethodDecember 8th, 2020
Racial Differences in Protein S Tokushima and Two Protein C Variants as Genetic Risk Factors for Venous ThromboembolismOctober 20th, 2020
Join now to see all